User fees for faster drug reviews. Are they helping or hurting the public health?
作者信息
Thompson L
出版信息
FDA Consum. 2000 Sep-Oct;34(5):25-9.
PMID:11590789
Abstract
摘要
相似文献
1
User fees for faster drug reviews. Are they helping or hurting the public health?加快药品审评的用户付费。它们对公众健康是有帮助还是有损害？
FDA Consum. 2000 Sep-Oct;34(5):25-9.
2
3
Paying for drug approvals--who's using whom?为药物审批付费——谁在利用谁？
N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.
4
User fees to fund faster reviews.
FDA Consum. 1993 Oct;27(8):19-21.
5
New drug law to speed scientific review.新药品法将加快科学审评。
Nature. 1992 Oct 15;359(6396):563. doi: 10.1038/359563a0.
6
The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.1992年《处方药使用者付费法案》：加快药品审批流程。
Healthspan. 1992 Dec;9(11):12-4.
7
Drug safety reform at the FDA--pendulum swing or systematic improvement?美国食品药品监督管理局的药物安全改革——是钟摆摆动还是系统性改进？
N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13.
8
PDUFA reauthorization--drug safety's golden moment of opportunity?《处方药用户收费法》重新授权——药物安全的黄金机遇时刻？
N Engl J Med. 2007 Apr 26;356(17):1703-4. doi: 10.1056/NEJMp078048. Epub 2007 Apr 13.
9
User fees to hasten FDA review.
Nature. 1992 Oct 15;359(6396):567. doi: 10.1038/359567b0.
10
A critical tipping point.一个关键的临界点。
US News World Rep. 2002 Apr 22;132(13):72.
Zotero 插件